Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · Feb 2022 Rapid communication · 29 Apr 2024 Practical Approaches to Endocrine Side Effects of Immune Checkpoint Inhibitors: Diagnosis and Clinical Interventions
Endocrine complications arising from the use of immune checkpoint inhibitors present unique challenges in oncology and require specialized diagnostic and management strategies. This article provides a comprehensive…
Case report · 27 Aug 2021 1,25(OH)2D Mediated Hypercalcemia Secondary to Drug Induced Sarcoid Like Reaction From Immune Checkpoint Inhibitors
Sarcoid Like Reactions (DISR) have recently been described as a potential consequence of immune checkpoint inhibitor therapy. However, hypercalcemia associated with DISR has not been reported. Clinical case ... case of…
Mini review · 29 Mar 2024 Immune Checkpoint Inhibitors: Revolutionizing Cancer Immunotherapy
Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic approach, marking a significant paradigm shift in cancer immunology. These inhibitors target key regulatory pathways of the immune system…
Perspective · 24 Mar 2023 Navigating the Side Effects of Immune Checkpoint Inhibitors
Short communication · 13 Jan 2020 Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer
Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint
Case report · 27 Jul 2022 Immune Checkpoint Inhibitor Induced Thrombocytopenia in Hepatocellular Carcinoma: A Case Report
Background: Immune checkpoint inhibitors have become part of the standard of care for many forms of solid tumors. Most immune checkpoint inhibitors target the PD (Programmed Cell Death
Editorial · 29 Aug 2024 Tumor Mutational Burden as a Biomarker: Predicting Response to Immune Checkpoint Inhibitors
crucial biomarker in the field of oncology, particularly for predicting patient responses to immune checkpoint inhibitors (ICIs). TMB quantifies the number of mutations within a tumor’s DNA, reflecting
Mini review · 27 Jun 2024 Pharmacogenomics of Immune Checkpoint Inhibitors: Cellular Responses and Therapeutic Strategies
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by harnessing the immune system to target tumors, leading to durable responses in various malignancies. However, the efficacy of ICIs varies…
Review article · 9 Aug 2022 The Blocking vs. Depletion Model of Immune Checkpoint Inhibitor Therapy for Cancer
Immune Checkpoint Inhibitor (ICI) therapy is the most exciting development in cancer treatments in recent years. As of the end of 2021, more than a hundred of clinical trials have
Mini review · 14 Sep 2023 Enhancing Immune Checkpoint Inhibitors with CRISPR: A Revolutionary Approach to Cancer Immunotherapy
Cancer immunotherapy has revolutionized the treatment landscape, with Immune Checkpoint Inhibitors (ICIs) playing a pivotal role in harnessing the body's immune system to combat cancer. However, not all patients…
Editorial · 30 Sep 2024 Advances in Immune Checkpoint Inhibitors: Transforming Therapeutic Strategies for Autoimmune Disorders and Cancer
Immune checkpoint inhibitors (ICIs) have revolutionized therapeutic strategies in both oncology and autoimmune disorders by modulating immune system responses. These agents target key regulatory proteins, such
Perspective · 30 Nov 2024 The Future of Immune Checkpoint Inhibitors in Cancer Treatment: Combining Immunotherapy with Targeted Therapies
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing the immune system to target and destroy tumor cells. Despite their significant success in cancers such as melanoma, non-small
Case report · 15 Jan 2021 Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report
Immune checkpoint inhibitors enhance T cell response against malignant cells and are standard of care in many tumor types. Disinhibition of cytotoxic T cells in normal organs and inhibitrion ... regulatory T cells can…
Short communication · 30 May 2022 A Dramatic Response to Immune Checkpoint Inhibitor in a Patient with a Bulky Intra Cardiac Metastasis in Renal Cell Carcinoma
therapies, including oral multitargeted Tyrosine Kinase Inhibitors (TKIs) and immune checkpoint inhibitors (IO), have significantly increased survival in the majority of patients with metastatic Renal Cell Carcinoma…
Conference abstract · 13 Apr 2022 CKTTD immune checkpoint inhibitors prognostic survival signature for lower-grade glioma
cancers. Our study reveals a new gene survival prognostic model from recent immune checkpoint inhibitor (ICIs) databases for glioma cancer. Methods: The Cancer Genome Atlas TCGA transcriptomic analysis and matching…
Perspective · 25 Apr 2022 Immune Checkpoint Inhibitors as a Treatment for Hepatocellular Carcinoma in the Early Stages Before Liver Transplantation
review examines the present and expanding amount of evidence on the use of immune checkpoint inhibitors in patients with advanced HCC who are awaiting liver transplantation, as well as many
Conference abstract · 17 Jun 2024 Impact of rash development for patients with non-small cell lung cancer receiving PD-1/PD-l1- based immune checkpoint inhibitor therapy
related skin rash is common in patients receiving PD-1/PD-L1-based immune checkpoint inhibitor therapy. This study aimed to explore whether development of rash is predicative of outcomes ... patients with non-small cell…
Review article · 8 Apr 2022 The Application and Progress of Immune Checkpoint Inhibitors in the Immunotherapy of Non-Small Cell Lung Cancer
For several years now, the therapeutic situation in the management of non
Case report · 12 Nov 2020 The Challenging Diagnosis of Myocarditis Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Immune Checkpoint Inhibitors induced Myocarditis is a serious adverse event. The clinical manifestation can be quite variable and the classic features of myocarditis are not always found. Although challenging…
Mini review · 29 Jun 2024 An Overview of Immune Checkpoint Inhibitors in the Treatment of Gynecological Cancer
Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic modality in the field of oncology, offering new hope for patients with various types of cancer, including gynecological malignancies…
Case report · 16 Jul 2019 A Dramatic Response to Immune Checkpoint Inhibitor in a Patient with a Bulky Intra Cardiac Metastasis in Renal Cell Carcinoma: A Case Report
Background: New therapies, including oral multitargeted Tyrosine Kinase Inhibitors (TKIs) and immune checkpoint inhibitors (IO), have significantly increased survival in the majority of patients with metastatic Renal…
Perspective · 18 Mar 2023 Treatment of Autoimmune Disorders with Immune Checkpoint Inhibitors is Revolutionary
Mini review · 30 Jan 2024 Navigating Cardiovascular Risks and Investigating Diagnostic and Therapeutic Approaches in Cancer Therapy: Convergence of Immune Checkpoint Inhibitors and Atherosclerosis
immune checkpoint inhibitors (ICIs) expands in clinical practice, our understanding of their potential adverse effects continues to grow. Arising substantiation indicates a connection between ICI remedy and an increased…
Review article · 25 May 2023 Immune Checkpoint Inhibitors and Atherosclerosis: Emerging Insights and Therapeutic Implications
immune checkpoint inhibitors (ICIs) expands in clinical practice, our understanding of their potential adverse effects continues to grow. Arising substantiation indicates a connection between ICI remedy and an increased…

